gray glp-1 Use of RAs Associated With Increased Risk of NAION in Patients With Diabetes GLP-1 Drugs | Scientific American

It is now recognized as the most common cause of chronic liver disease, with an estimated prevalence of 32.4% in the general population

A groundbreaking study presented at the 2024 American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting offers a clear answer and it could reshape the conversation around medical versus surgical weight loss

Alternative treatment options should be discussed if fertility concerns are paramount

While the human body can produce a certain amount of carnitine endogenously, it heavily relies on dietary intakeprimarily from animal proteins like red meatto meet its daily metabolic requirements